Nm23‐H1 inhibits lung cancer bone‐specific metastasis by upregulating miR‐660‐5p targeted SMARCA5
Abstract Background Nm23‐H1 gene has been found to be an inhibitor of tumor metastasis in lung cancer. MicroRNAs (miRNAs) play key roles in tumor metastasis through multiple signaling pathways. This study explored whether the nm23‐H1 gene could inhibit invasion and metastasis of lung cancer cells by...
Main Authors: | Cheng Ai, Guangzhi Ma, Yunfu Deng, Qiangqiang Zheng, Yingcai Gen, Wen Li, Yang Li, Lingling Zu, Qinghua Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-03-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.13308 |
Similar Items
-
The chromatin-remodeling enzyme Smarca5 regulates erythrocyte aggregation via Keap1-Nrf2 signaling
by: Yanyan Ding, et al.
Published: (2021-10-01) -
The Emerging Roles and Clinical Potential of circSMARCA5 in Cancer
by: Changning Xue, et al.
Published: (2022-09-01) -
CircSMARCA5 functions as a potential biomarker for clinicopathology and therapy in solid tumors: A systematic review and meta‐analysis
by: Chaomin Pan, et al.
Published: (2023-09-01) -
Circ-SMARCA5 suppresses progression of multiple myeloma by targeting miR-767-5p
by: Haiyan Liu, et al.
Published: (2019-10-01) -
Circ_0008305‐mediated miR‐660/BAG5 axis contributes to hepatocellular carcinoma tumorigenesis
by: Fuguo Yan, et al.
Published: (2021-02-01)